3'甲酰基苯并冠醚的合成

本文用邻香兰醛作为起始原料,经过脱甲基反应,而制得2,3-二羟基苯甲醛,然后,在DMF中分多甘醇二对甲苯磺酸脂和氢方钠(方法A)或多醉二醇二氯化物和碳酸钾(方法B)长时间加热反应,即合成了3'-甲酰锘苯并冠醚和3',3'-和3'6'-二甲酰基二苯并冠醚.     

2',5'-二氢-1'H-吡咯骈[3',4':1,2][60]富勒烯衍生物的合成

以甘氨酸乙酯盐酸与取代的苯甲醛为原料,制得了一系列亚胺,然后用亚胺与C~6~0反应,得到带有不同取代基的吡咯烷骈[60]富勒烯衍生物.经^1HNMR,^1^3CNMR,FT-IR,UV-vis以及TOF-SMS等方法对所得化合物结构进行了表征,并进行了产物的生物活性测试。     

2-芳胺基-5-[5'-氨基-1'-(4"-氯苯基)-1',2',3'-三唑-4'-基]-1,3,4-噻二唑的合成

1-[5'-氨基-1'-(4"-氯苯基)-1,2,3-三唑-4'-甲酰基]-4-芳基-3-氨基硫脲在浓硫酸催化下环化得到2-芳胺基-5-[5'-氨基-1'-(4"-氯苯基)-1',2',3',-三唑-4'-基]-1,3,4-噻二唑2a-i, 依此法合成了九个标题化合物, 收率为30-74%。化合物2i的结构用X-光衍射单晶分析确证。     

四(4,4',4',4''-N,N-二氨基)四苯乙烯光致发光与分子的构象效应

利用还原偶联方法合成出新化合物四(4,4',4',4''-N,N-二氨基)四苯乙烯（ TDETE）。通过测定该化合物在溶液、掺杂聚合物中及晶体粉末的稳态-瞬态荧光光 谱、荧光量子产率和辐射衰变速率常数等。讨论了分子的构象效应等因素对TDETE 光致发光行为的影响。在一定浓度下TDETE溶液存在着三个发光带，分别为全扭曲 构象分子（位于345nm附近的发光I带）、半扭曲构象分子（位于430nm附近的发光 II带）和激基缔合物（530发光III带）的辐射衰变所致。在聚合物（PMMA）中，一 方面由于分子单键的自由旋转扭曲受到遏制，表现为II带的辐射衰变速率常数(kf 值)增大、同时非辐射衰变速率常数knf值减小；另一方面，TDETE分子之间相互作 用得到加强而有利一缔合物形成，结果，使发光II带和III带合二为一出现强而宽 的发射峰，荧光量子产率从溶液中的0.055提高到0.855。此外，在PMM介制裁中观 测到TDETE分子聚集体在626nm处的发光带（IV），数粉末态中聚集体IV带的强度骤 增，峰值波长红移至650nm。     

手性-3, 5-二取代-1', 2', 4'-三唑-[3', 4'-b]-2, 4-二氢间 噻二嗪的合成及 生物活性

以3-芳基-5-巯基-1,2,4-均三唑为原料,和甲醛及S-(-)-α-苯乙胺在酸催化作用下合成了6种新的化合物。研究了合成反应的条件。通过元素分析、IR、^1HNMR、和MS确证了其结构,测定了比旋光度和生物活性。结果表明,一些化合物具有一定的抗菌活性。     

1-(2'-苯基-1', 2', 3'-三唑-4'-甲酰基)-4-芳基氨基硫脲及其 环化产物的合 成

以2-苯基-1,2,3-三唑-4-甲酰肼为原料合成了几种新的1-(2'-苯基-1',2',3'-三唑-4'-甲酰基)-4-芳基氨基硫脲,在不同条件下环化,制得一系列新的1,3,4-噻二唑、1,3,4-恶二唑和1,2,4-均三唑衍生物。化合物的结构经元素分析、IR、^1HNMR和MS确证,并对其波谱性质进行了讨论。     

由4',4''-二羟基-2-甲酸－三苯基甲烷及其衍生物制备高碳超支化芳香聚酯

合成了一系列含羟基和乙酰氧基的超支化聚酯,将4',4'二羟基-2-甲酸－三 苯基甲烷（酚酞啉）直接缩聚和将4~＇,4~＂-二羟基-2-甲酸－三苯基甲烷进行酯 交换反应都成功得到了超支化聚酯,以PS作标准物,由GPC测得的重均分子量为 2000到8000,~13C NMR测试表明聚合物支化度略高于50%,聚酯的玻璃化转变温度 依赖于末端和侧基官能团类型,该超支化聚酯末端含有反应性官能团,具有类似线 性高分子的高的热稳定性,相比之下,由于其大分子的形状和官能团的影响,末端 为乙酰氧基的超支化聚枉费显示了优良的溶解性能,这与一般线性高分子大不相同 ,由于氢键的存在,末端为羟基的超支化聚酯的溶解性能不佳,但是酸酯显示了 优良的溶解性能,这与一般线性高分子大不相同,由于氢键的存在,末端为羟基的 超支化聚枉费的溶解性能不佳,但是酸化可破坏氢键网络,得到的超支化聚酯可深 于一般有机溶剂。     

由4',4'-二羟基-2-甲酸－三苯基甲烷及其衍生物制备高碳超支化芳香聚酯

合成了一系列含羟基和乙酰氧基的超支化聚酯，将4',4'二羟基-2-甲酸－三 苯基甲烷（酚酞啉）直接缩聚和将4~＇,4~＂-二羟基-2-甲酸－三苯基甲烷进行酯 交换反应都成功得到了超支化聚酯，以PS作标准物，由GPC测得的重均分子量为 2000到8000，~13C NMR测试表明聚合物支化度略高于50%，聚酯的玻璃化转变温度 依赖于末端和侧基官能团类型，该超支化聚酯末端含有反应性官能团，具有类似线 性高分子的高的热稳定性，相比之下，由于其大分子的形状和官能团的影响，末端 为乙酰氧基的超支化聚枉费显示了优良的溶解性能，这与一般线性高分子大不相同 ，由于氢键的存在，末端为羟基的超支化聚酯的溶解性能不佳，但是酸酯显示了 优良的溶解性能，这与一般线性高分子大不相同，由于氢键的存在，末端为羟基的 超支化聚枉费的溶解性能不佳，但是酸化可破坏氢键网络，得到的超支化聚酯可深 于一般有机溶剂。     

酰氨基硫脲及相关杂环衍生物的研究XXIX: 2-(3'-溴苯胺基)-5-[5'-氨基-1'-(4"-氯苯基)-1',2',3'-三唑-4'-基]-1,3,4-噻二唑的晶体结构

经1-[5'-氨基-1'-(4"-氯苯基)-1',2',3'-三唑-4'-甲酰基]-4-(3'-溴苯基)-3-氨基硫脲在浓硫酸作用下制得2-(3'-溴苯胺基)-5-[5'-氨基-1'-(4"-氯苯基)-1',2',3'-三唑-4'-基]-1,3,4-噻二唑化合物。该化合物的晶体结构经X射线衍射分析确定, 化合物属三斜晶系, P1空间群, a=1.1784(2), b=1.4455(2),c=1.1353(1)nm; α=100.68(1), β=109.50(1), γ=79.89(1)°; V=1.7779nm^3; 分子式C~1~6H~1~1BrClN~7S, Mr=448.75; Dc=1.673g/cm^3, Z=4,μ=58.16cm^-^1, 最终偏离因子R=0.084, Rw=0.086。分析化合物的键长, 键角数据表明, 该分子具有离域π键结构。     

酰氨基硫脲及相关杂环衍生物的研究XXIX: 2-(3'-溴苯胺基)-5-[5'-氨基-1'-(4"-氯苯基)-1',2',3'-三唑-4'-基]-1,3,4-噻二唑的晶体结构

经1-[5'-氨基-1'-(4"-氯苯基)-1',2',3'-三唑-4'-甲酰基]-4-(3'-溴苯基)-3-氨基硫脲在浓硫酸作用下制得2-(3'-溴苯胺基)-5-[5'-氨基-1'-(4"-氯苯基)-1',2',3'-三唑-4'-基]-1,3,4-噻二唑化合物。该化合物的晶体结构经X射线衍射分析确定, 化合物属三斜晶系, P1空间群, a=1.1784(2), b=1.4455(2),c=1.1353(1)nm; α=100.68(1), β=109.50(1), γ=79.89(1)°; V=1.7779nm^3; 分子式C~1~6H~1~1BrClN~7S, Mr=448.75; Dc=1.673g/cm^3, Z=4,μ=58.16cm^-^1, 最终偏离因子R=0.084, Rw=0.086。分析化合物的键长, 键角数据表明, 该分子具有离域π键结构。     

6－S－（取代的三或四唑杂环基）－1，2：3，4－二－O－异亚丙基－α-D吡喃型半乳糖的合成研究

报道了6－O－对甲苯磺酰基－1，2：3，4－二－O－异亚丙基－α-D吡喃型半 乳糖（3）与取代的3－巯基三唑或5－巯基四唑4a-4c或5a-5f的亲核取代反应，合 成了9个6－S－（取代的三或四唑杂环基）－1，2：3，4－二－O－异亚丙基－α- D吡喃型半乳糖（6a-6i），通过元素分析，IR，NMR和MS确证了上述化合物的结构 ，并经分子模型计算进行了其构象分析。     

β'-芳氨基ａ,β-不饱和酮及其盐酸盐与苯肼的反应

本文通过β'-芳氨基ａ,β-不饱和酮及其盐酸盐与苯肼反应的研究,进一步扩大了β-芳氨基酮在有机合成上的应用范围,并为了-β-芳氨乙基-2-吡唑啉化合物和1,2,8-三氮双环[3,3,0]辛烷找到了切实可行的合成方法,具有原料易得、操作简便、易于纯化等特点.     

IN SITU GENERATION OF PSORALENS BY PHOTOLYSIS OF WATER-SOLDBLE PRECURSORS

Abstract— The poor water solubility of typical photochemotherapeutic psoralens restricts their utility in aqueous solutions and commonly requires the use of organic co-solvents in photobiological studies. This paper describes the preparation of readily water-soluble "pre-psoralens", (Z)-3-[5-(4,6-dimethoxy)benzofuranyl]propenoic acid (3) and (Z)-3-[5-(6,7-dimethoxy)benzofuranyl]propenoic acid (4), and their novel photocyclization in aqueous media to give 5-methoxypsoralen (5-MOP) and 8-methoxypsoralen (8-MOP), respectively. Quantum efficiencies, measured at 308 nm for the cyclization, are 12. 1 × 10^-3 for 3 → 5-MOP and 2.7 × 10^-3 for 4 → 8-MOP. 5-Methoxyisopsoralen (5-MOiP, 5) is a side product from the photolysis of 3. Photocross-linking of calf thymus DNA is effected when the "pre-psoralens" are irradiated with 308 or 355 nm (3 only) light.     

1,1-二卤代-1-烯烃的制备及其在有机合成中的应用

1,1-二卤代-1-烯烃是有机化学中常见的合成片断,在合成化学中已得到了广泛的应用。该综述介绍了这一类化合物常见的制备方法以及反应的适用范围,并详细讨论了该类化合物在有机合成中的应用：(1)1,1-二卤代-1-烯烃在镁、有机锂、锌/溴化亚铜、二碘化钐、零价钯等金属或金属试剂作用下,发生α-消除反应生成烯基卡宾中间体的反应;(2)1,1-二卤代-1-烯烃在合成杂环以及核苷类似物等方面的应用。对于这类化合物在钯催化下的分子内(间)的偶联反应以及利用分子内的双环碳钯化反应,合成环状化合物等等方面的研究进展,也进行了详细的讨论。     

A FLOW LINEAR DICHROISM STUDY OF THE ORIENTATION OF 4'',5''-PSORALEN-DNA PHOTOADDUCTS

Abstract— The flow linear dichroism properties of covalent adducts derived from the photochemical binding of various psoralen derivatives to salmon sperm DNA were investigated. The psoralens studied include bifunctional derivatives (8-methoxypsoralen,5-methoxypsoralen, tetrahydropyrido [3,4: 4',5'] psoralen) and monofunctional derivatives (pyrido [3,4-c] psoralen, 7-methylpyrido [3,4-c] psoralen, 3-carbethoxypsoralen). The orientation of the psoralen moieties (furan-side monoadducts) relative to the orientation of the DNA bases was determined. All of the furan-side monoadducts are characterized by a similar orientation, with mean angles between the psoralen moiety and the normals of the planes of the DNA bases ranging between 70° and values close—but not equal—to 90°. The results are consistent with a pseudo-intercalative adduct geometry, most probably involving stacking interactions with the DNA bases.     

无外加催化剂条件下邻取代芳香醛与5, 5-二甲基-1, 3-环己二 酮的反应研究

在DMF溶剂中,不外加催化剂使邻取代芳香醛(1)与5,5-二甲基-1,3-环己二酮(2)发生缩合和加成反应生成3,3,6,6-四甲基-4a-羟基-9-芳基-1,8-二氧代-2,3,4,4a,5,6,7,8,9,9a-十氢化-1H-氧杂蒽(3a-3d)。在同样条件下,邻羟基芳香醛与5,5-二甲基-1,3-环己二酮则发生缩合、加成和脱水反应生成3,3-二甲基-9-(5,5-二甲基-3-羟基-2-环己烯-1-酮-2-基)-1-氧代-2,3,4,9-四氢化-1-氧杂蒽(4a-4b)。用单晶X-射线分析法确定了产物3a和4a的晶体结构。     

PHOTOREACTION OF 8-METHOXYPSORALEN WITH THYMIDINE

Abstract— The photoreaction of 8-methoxypsoralen (8-MOP) with thymidine in solid film state yielded two 4', 5'-monoadducts (a pair of diastereomers) and three 3,4-monoadducts. The stereochemistry of two 4', 5'-monoadducts was found to be cis-syn and trans-syn and one 3,4-monoadduct was cis-anti. In addition to these monoadducts, 3,4-, 4', 5'-biadducts were also formed during the reaction, but the isolation of each isomer of these adducts was not successful; however, the formation of these biadducts was confirmed by UV, IR, TLC and photosplitting experiments.     

IMPROVED HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC ANALYSIS OF 8-METHOXYPSORALEN MONOADDUCTS and CROSS-LINKS IN POLYNUCLEOTIDE, DNA, and CELLULAR SYSTEMS: ANALYSIS OF SPLIT-DOSE PROTOCOLS

Abstract— The distribution of 8-methoxypsoralen-thymidine photoadducts from polynucleotides, calf thymus DNA and mammalian cells treated with [³H]8-methoxypsoralen under a variety of irradiation conditions was determined using high-performance liquid chromatography and scintillation analysis. The split-dose protocol, with samples treated with 8-methoxypsoralen and low doses of long-wavelength UV radiation to generate monoadducts, washed to remove unreacted 8-methoxypsoralen, then irradiated further to convert the monoadducts to cross-links, was examined. The photoadduct distribution in the first step is dependent upon the UVA dose and the wavelength of the radiation, but it is relatively independent of 8-methoxypsoralen concentration. Low fluence and longer wavelengths generate mainly 4',5'-monoadducts, whereas higher fluences and shorter wavelengths yield more cross-links. The second irradiation step converts the 4',5'-monoadducts to cross-links as well as to 3,4-monoadducts. The overall yield of cross-links after the second irradiation step is not dependent upon the wavelength used in the first step. Cellular studies demonstrated that the split-dose protocol is applicable to mammalian systems. These results may afFect the interpretation of mutagenesis studies based on the split-dose protocol, because the second step can convert 4',5'-monoadducts to both 3,4-monoadducts, the expected cross-links. Therefore, interpretations that link increases in mutagenicity after the second step in a split-dose study solely to cross-link formation may need re-examination.     

Purines, pyrimidines, and related fused systems. 21. Oxidative amination of 3-chloro-6,8-dimethylpyrimido[4,5-c]pyridazine-5,7(6H,8H)-dione

Oxidative amination of 3-chloro-6,8-dimethylpyrimido[4,5-c]pyridazine-5,7(6H,8H)-dione with primary alkylamines and potassium amide in liquid ammonia gives rise to the corresponding 4-amino derivatives as the major products. The reactions with acyclic secondary amines are accompanied by annelation of the pyrrole moiety to the starting heterosystem to form 1-R-3-R"-6,8-dimethylpyrrolo[2",3";3,4]pyrimido[4,5-c]pyridazine-7,9(6H,8H)-diones. The reaction with piperidine as the aminating agent occurs exclusively as aminodehalogenation. The Sonogashira cross-coupling of 4-amino-3-chloro-6,8-dimethylpyrimido[4,5-c]pyridazine-5,7(6H,8H)-diones with terminal alkynes affords 1-R-2-R"-6,8-dimethylpyrrolo[3",2";3,4]pyrimido[4,5-c]pyridazine-7,9(6H,8H)-diones.     

First Total Synthesis of (±)-Ponganone Ⅲ

In recent years, the synthesis and pharmacology of pyranoflavanoids have been extensively investigated due to their wide range of pharmacological properties^[1-3]. Ponganone Ⅲ^[4],a new natural pyranoflavanone isolated from the Pongamia pinnala, was identified as (2S)-3',4'-dimethoxy-6',6"-dimethylpyrano-[2",3":7,8]-flavanone (2) on the basis of spectra data. Its precursor,3,4-dimethoxy-2'-hydroxy-6",6"-dimethylchromeno-[2",3":4',3']-chalcone (1) is also a new natural product^[5] isolated from the roots of Lonchocarpus subglaucescent. Their total synthesis have not been reported. Herein, we wish to report the first total synthesis of compounds 1 and 2 in order to confirm the proposed structure and further more to evaluate its biological activities.